Literature DB >> 17721874

Gene therapy clinical trials worldwide to 2007--an update.

Michael L Edelstein1, Mohammad R Abedi, Jo Wixon.   

Abstract

To date, over 1340 gene therapy clinical trials have been completed, are ongoing or have been approved worldwide. In 1997 we set up a database to bring together global information on gene therapy clinical trials as comprehensively as possible. The data are compiled and regularly updated from official agency sources, published literature, conference presentations and posters and from information kindly provided by investigators or trial sponsors themselves. This review updates our descriptive overview of the data in 2004 1, presenting our analysis of the clinical trials that, to the best of our knowledge, have been or are being performed worldwide. As of July 30 2007, we have stored entries on 1309 trials in 28 countries. We have analyzed the geographical distribution of trials, the disease indications (or other reasons) for trials, the proportions to which different vector types are used, and which genes have been transferred. Details of the analyses presented, and our interactive, searchable database can be found on The Journal of Gene Medicine Gene Therapy Clinical Trials Worldwide website at: http://www.wiley.co.uk/genmed/clinical. Copyright 2007 John Wiley & Sons, Ltd.

Mesh:

Year:  2007        PMID: 17721874     DOI: 10.1002/jgm.1100

Source DB:  PubMed          Journal:  J Gene Med        ISSN: 1099-498X            Impact factor:   4.565


  128 in total

1.  Eight years of clinical improvement in MPTP-lesioned primates after gene therapy with AAV2-hAADC.

Authors:  Piotr Hadaczek; Jamie L Eberling; Philip Pivirotto; John Bringas; John Forsayeth; Krystof S Bankiewicz
Journal:  Mol Ther       Date:  2010-06-08       Impact factor: 11.454

2.  Polymers for gene delivery: Charged for success.

Authors:  Enrico Mastrobattista; Wim E Hennink
Journal:  Nat Mater       Date:  2011-12-15       Impact factor: 43.841

3.  Performance of high quality minicircle DNA for in vitro and in vivo gene transfer.

Authors:  Dennis Kobelt; Martin Schleef; Marco Schmeer; Jutta Aumann; Peter M Schlag; Wolfgang Walther
Journal:  Mol Biotechnol       Date:  2013-01       Impact factor: 2.695

Review 4.  Gene therapy: a pharmacokinetic/pharmacodynamic modelling overview.

Authors:  Zinnia P Parra-Guillén; Gloria González-Aseguinolaza; Pedro Berraondo; Iñaki F Trocóniz
Journal:  Pharm Res       Date:  2010-04-13       Impact factor: 4.200

5.  Cationic liposome-nucleic acid complexes: liquid crystal phases with applications in gene therapy.

Authors:  C R Safinya; K K Ewert; Cecília Leal
Journal:  Liq Cryst       Date:  2011-11-22

Review 6.  Progress and challenges in viral vector manufacturing.

Authors:  Johannes C M van der Loo; J Fraser Wright
Journal:  Hum Mol Genet       Date:  2015-10-30       Impact factor: 6.150

Review 7.  Current status of gene therapy for rheumatoid arthritis.

Authors:  Daniel F Gaddy; Paul D Robbins
Journal:  Curr Rheumatol Rep       Date:  2008-10       Impact factor: 4.592

8.  A ligand-mediated nanovector for targeted gene delivery and transfection in cancer cells.

Authors:  Omid Veiseh; Forrest M Kievit; Jonathan W Gunn; Buddy D Ratner; Miqin Zhang
Journal:  Biomaterials       Date:  2008-11-05       Impact factor: 12.479

Review 9.  Barriers for retinal gene therapy: separating fact from fiction.

Authors:  Rajendra Kumar-Singh
Journal:  Vision Res       Date:  2008-06-18       Impact factor: 1.886

10.  Development of a gene therapy virus with a glucocorticoid-inducible MMP1 for the treatment of steroid glaucoma.

Authors:  Maria-Grazia Spiga; Teresa Borrás
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-01-20       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.